4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-25-047122
President & CIO sold 1,330,868 shares at an average $21.72 ($28,902,500)
- President & CIO disposed of 1,867,367 shares (other)
- President & CIO acquired 3,198,235 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sukhatme Mayukh President & CIO | 2025-12-29 | Option exercise | +748,358 | $12.68 | $9,489,179 | 19,584,905 | D |
| Sukhatme Mayukh President & CIO | 2025-12-29 | Sale | −311,873 | $21.74 | $6,780,119 | 19,273,032 | D |
| Sukhatme Mayukh President & CIO | 2025-12-29 | Other disposition | −436,485 | $21.74 | $9,489,184 | 18,836,547 | D |
| Sukhatme Mayukh President & CIO | 2025-12-31 | Option exercise | +2,449,877 | $12.68 | $31,064,440 | 21,286,424 | D |
| Sukhatme Mayukh President & CIO | 2025-12-31 | Sale | −1,018,995 | $21.71 | $22,122,381 | 20,267,429 | D |
| Sukhatme Mayukh President & CIO | 2025-12-31 | Other disposition | −1,430,882 | $21.71 | $31,064,448 | 18,836,547 | D |
| Derivatives | |||||||
| Sukhatme Mayukh President & CIO | 2025-12-29 | Option exercise · Stock Option (Right to Buy) | −748,358 | 555,840 | D | ||
| Sukhatme Mayukh President & CIO | 2025-12-31 | Option exercise · Stock Option (Right to Buy) | −2,449,877 | 95,718 | D | ||
| Open-market sales · 1,330,868 sh · avg $21.72 · $28,902,500 | |||||||
Loading xslF345X05/form4.xml…